Search

Your search keyword '"P., Zambon"' showing total 25 results
Start Over Author "P., Zambon" Journal journal of hypertension
25 results on '"P., Zambon"'

3. Low-blood pressure phenotype underpins the tendency to reflex syncope

Author

Brignole, Michele, Rivasi, Giulia, Sutton, Richard, Kenny, Rose Anne, Morillo, Carlos A., Sheldon, Robert, Raj, Satish R., Ungar, Andrea, Furlan, Raffaello, van Dijk, Gert, Hamdan, Mohamed, Hamrefors, Viktor, Engström, Gunnar, Park, Chloe, Soranna, Davide, Zambon, Antonella, Parati, Gianfranco, and Fedorowski, Artur

Abstract

Supplemental Digital Content is available in the text

Published
2021
Full Text
View/download PDF

4. SEX RELATED DIFFERENCES IN BLOOD PRESSURE VARIABILITY IN HYPERTENSIVE PATIENTS: CV-PREVITAL STUDY

Author

Croce, Alessandro, Bilo, Grzegorz, Pengo, Martino, Soranna, Davide, Sucapuca, Richard, Amato, Franca, Favè, Marta, Marino, Antonietta, Pellegrinelli, Veronica, Molteni, Serena, Nardin, Elisa, Parisi, Marco, Romeo, Claudia, Losa, Lorenzo, Saccà, Angelo Maria, De Virgiliis, Giorgia, Colella, Chiara, Zambon, Antonella, Ferrara, Pietro, and Parati, Gianfranco

Published
2024
Full Text
View/download PDF

5. RESIDENCE AT HIGH ALTITUDE IS ASSOCIATED WITH LOWER CONVENTIONAL AND AMBULATORY BLOOD PRESSURE THAN LIVING AT SEA LEVEL IN THE GENERAL POPULATION OF PERU. HIGHCARE-LAPS STUDY

Author

Bilo, Grzegorz, Villafuerte, Francisco C., Zanotti, Lucia, Soranna, Davide, Nava, Sara, Rusconi, Valentina, Pengo, Martino F., Croce, Alessandro, Lombardi, Carolina, Macarlupu, Jose Luis, Bermudez, Daniela, Sosa, Jose’ Manuel, Carcamo, Cesar P., Zambon, Antonella, and Parati, Gianfranco

Published
2024
Full Text
View/download PDF

10. Continuation of the ESH-CHL-SHOT trial after publication of the SPRINT: rationale for further study on blood pressure targets of antihypertensive treatment after stroke

Author

Zanchetti, Alberto, Liu, Lisheng, Mancia, Giuseppe, Parati, Gianfranco, Grassi, Guido, Stramba-Badiale, Marco, Silani, Vincenzo, Bilo, Grzegorz, Corrao, Giovanni, Zambon, Antonella, Scotti, Lorenza, Zhang, Xinhua, Guan, Ting Rui, Zhang, Yuqing, Zhang, Xuezhong, Berge, Eivind, Redon, Josep, Narkiewicz, Krzysztof, Dominiczak, Anna, Nilsson, Peter, Viigimaa, Margus, Laurent, Stéphane, Agabiti-Rosei, Enrico, Wu, Zhaosu, Zhu, Dingliang, Rodicio, José Luis, Ruilope, Luis Miguel, Martell-Claros, Nieves, Pinto, Fernando, Schmieder, Roland E., Burnier, Michel, Banach, Maciej, Cifkova, Renata, Farsang, Csaba, Konradi, Alexandra, Lazareva, Irina, Sirenko, Yuriy, Dorobantu, Maria, Postadzhiyan, Arman, Accetto, Rok, Jelakovic, Bojan, Lovic, Dragan, Manolis, Athanasios J., Stylianou, Philippos, Dicker, Dror, Wei, Gangzhi, Xu, Chengbin, Xie, Hengge, Coca, Antonio, O’Brien, John, and Ford, Gary

Published
2016
Full Text
View/download PDF

11. Blood pressure and LDL-cholesterol targets for prevention of recurrent strokes and cognitive decline in the hypertensive patient

Author

Zanchetti, Alberto, Liu, Lisheng, Mancia, Giuseppe, Parati, Gianfranco, Grassi, Guido, Stramba-Badiale, Marco, Silani, Vincenzo, Bilo, Grzegorz, Corrao, Giovanni, Zambon, Antonella, Scotti, Lorenza, Zhang, Xinhua, Wang, HayYan, Zhang, Yuqing, Zhang, Xuezhong, Guan, Ting Rui, Berge, Eivind, Redon, Josep, Narkiewicz, Krzysztof, Dominiczak, Anna, Nilsson, Peter, Viigimaa, Margus, Laurent, Stéphane, Agabiti-Rosei, Enrico, Wu, Zhaosu, Zhu, Dingliang, Rodicio, José Luis, Ruilope, Luis Miguel, Martell-Claros, Nieves, Pinto, Fernando, Schmieder, Roland E., Burnier, Michel, Banach, Maciej, Cifkova, Renata, Farsang, Csaba, Konradi, Alexandra, Lazareva, Irina, Sirenko, Yuriy, Dorobantu, Maria, Postadzhiyan, Arman, Accetto, Rok, Jelakovic, Bojan, Lovic, Dragan, Manolis, Athanasios J., Stylianou, Philippos, Erdine, Serap, Dicker, Dror, Wei, Gangzhi, Xu, Chengbin, Xie, Hengge, Coca, Antonio, O’Brien, John, and Ford, Gary

Abstract

The SBP values to be achieved by antihypertensive therapy in order to maximize reduction of cardiovascular outcomes are unknown; neither is it clear whether in patients with a previous cardiovascular event, the optimal values are lower than in the low-to-moderate risk hypertensive patients, or a more cautious blood pressure (BP) reduction should be obtained. Because of the uncertainty whether ‘the lower the better’ or the ‘J-curve’ hypothesis is correct, the European Society of Hypertension and the Chinese Hypertension League have promoted a randomized trial comparing antihypertensive treatment strategies aiming at three different SBP targets in hypertensive patients with a recent stroke or transient ischaemic attack. As the optimal level of low-density lipoprotein cholesterol (LDL-C) level is also unknown in these patients, LDL-C-lowering has been included in the design.

Published
2014
Full Text
View/download PDF

12. Blood pressure and low-density lipoprotein-cholesterol lowering for prevention of strokes and cognitive decline

Author

Zanchetti, Alberto, Liu, Lisheng, Mancia, Giuseppe, Parati, Gianfranco, Grassi, Guido, Stramba-Badiale, Marco, Silani, Vincenzo, Bilo, Grzegorz, Corrao, Giovanni, Zambon, Antonella, Scotti, Lorenza, Zhang, Xinhua, Wang, HayYan, Zhang, Yuqing, Zhang, Xuezhong, Guan, Ting Rui, Berge, Eivind, Redon, Josep, Narkiewicz, Krzysztof, Dominiczak, Anna, Nilsson, Peter, Viigimaa, Margus, Laurent, Stéphane, Agabiti-Rosei, Enrico, Wu, Zhaosu, Zhu, Dingliang, Rodicio, José Luis, Ruilope, Luis Miguel, Martell-Claros, Nieves, Pinto, Fernando, Schmieder, Roland E., Burnier, Michel, Banach, Maciej, Cifkova, Renata, Farsang, Csaba, Konradi, Alexandra, Lazareva, Irina, Sirenko, Yuriy, Dorobantu, Maria, Postadzhiyan, Arman, Accetto, Rok, Jelakovic, Bojan, Lovic, Dragan, Manolis, Athanasios J., Stylianou, Philippos, Erdine, Serap, Dicker, Dror, Wei, Gangzhi, Xu, Chengbin, Xie, Hengge, Coca, Antonio, O’Brien, John, and Ford, Gary

Abstract

It is well established by a large number of randomized controlled trials that lowering blood pressure (BP) and low-density lipoprotein cholesterol (LDL-C) by drugs are powerful means to reduce stroke incidence, but the optimal BP and LDL-C levels to be achieved are largely uncertain. Concerning BP targets, two hypotheses are being confronted: first, the lower the BP, the better the treatment outcome, and second, the hypothesis that too low BP values are accompanied by a lower benefit and even higher risk. It is also unknown whether BP lowering and LDL-C lowering have additive beneficial effects for the primary and secondary prevention of stroke, and whether these treatments can prevent cognitive decline after stroke.

Published
2014
Full Text
View/download PDF

13. Relationships of different types of event to cardiovascular death in trials of antihypertensive treatment

Author

Zambon, Antonella, Arfè, Andrea, Corrao, Giovanni, and Zanchetti, Alberto

Abstract

Guidelines for management of cardiovascular diseases stratify absolute cardiovascular risk into categories with a high-risk threshold defined at a 20 cardiovascular events risk in 10 years, but it is unclear whether only major events or the Framingham-extended definition should be considered. The 2013 ESH-ESC hypertension guidelines, instead, define cardiovascular risk as a risk of cardiovascular death in 10 years, as in the SCORE model, setting the threshold for high risk at the 5 level. It would be therefore convenient to know the quantitative relationship between the risks of the different outcomes adopted by the different guidelines, especially because some outcome definitions include serious nonfatal cardiovascular events relevant in cardiovascular prevention. We have therefore analysed these relationships in trials of antihypertensive therapy as an aid to defining total cardiovascular risk in hypertensive patients.

Published
2014
Full Text
View/download PDF

18. Better compliance to antihypertensive medications reduces cardiovascular risk

Author

Corrao, Giovanni, Parodi, Andrea, Nicotra, Federica, Zambon, Antonella, Merlino, Luca, Cesana, Giancarlo, and Mancia, Giuseppe

Abstract

The effect of compliance with antihypertensive medications on the risk of cardiovascular outcomes in a population without a known history of cardiovascular disease has been addressed by a large population-based prospective, cohort study carried out by linking Italian administrative databases.

Published
2011
Full Text
View/download PDF

21. Discontinuation of and changes in drug therapy for hypertension among newly-treated patients a population-based study in Italy

Author

Corrao, Giovanni, Zambon, Antonella, Parodi, Andrea, Poluzzi, Elisabetta, Baldi, Ileana, Merlino, Luca, Cesana, Giancarlo, and Mancia, Giuseppe

Abstract

To assess rates and determinants of treatment discontinuation of or changes in initial antihypertensive drug therapy in a large cohort of patients from Lombardia (Italy).

Published
2008
Full Text
View/download PDF

22. C-reactive protein and interleukin-6 in vascular disease

Author

Rattazzi, Marcello, Puato, Massimo, Faggin, Elisabetta, Bertipaglia, Barbara, Zambon, Alberto, and Pauletto, Paolo

Abstract

Recent advances in basic science have shown that atherosclerosis should be considered as a chronic inflammatory process, and that a pivotal role of inflammation is evident from initiation through progression and complication of atherosclerosis. In the past few years many studies have examined the potential for biochemical markers of inflammation to act as predictors of coronary heart disease (CHD) risk in a variety of clinical settings. Several large, prospective epidemiological studies have shown consistently that C-reactive protein (CRP) and interleukin-6 (IL-6) plasma levels are strong independent predictors of risk of future cardiovascular events, both in patients with a history of CHD and in apparently healthy subjects. These molecules could be useful to complement traditional risk factors, as well as to identify new categories of subjects prone to atherosclerosis development. An intriguing question is whether these inflammatory molecules simply represent sensitive markers of systemic inflammation or if they actively contribute to atherosclerotic lesion formation and instability. In this paper we will review the evidence concerning the cardiovascular prognostic value and the potential direct involvement of CRP and IL-6 in atherogenesis.

Published
2003

23. Reduced susceptibility to oxidation of lowdensity lipoprotein in patients with overproduction of nitric oxide Bartter's and Gitelman's syndrome

Author

Calò, Lorenzo, Sartore, Giovanni, Bassi, Andrea, Basso, Cristina, Bertocco, Sandra, Marin, Raffaella, Zambon, Sabina, Cantaro, Salvatore, D'Angelo, Angela, Davis, Paul A., Manzato, Enzo, and Crepaldi, Gaetano

Abstract

The oxidation of low-density lipoprotein (LDL) might play an important role in the development of atherosclerosis.

Published
1998

24. 1B.11

Author

Bilo, G., Faini, A., Liu, X., Lisi, E., Hoshide, S., Salerno, S., Giuliano, A., Gregorini, F., Revera, M., Lang, M., Caravita, S., Soranna, D., Zambon, A., Lombardi, C., and Parati, G.

Abstract

Blood pressure (BP) measuring devices may become inaccurate at high altitude due to low barometric pressure. Aim of this study was to assess the changes in the accuracy of different types of BP measuring devices between sea level and high altitude, taking auscultatory measurements with mercury sphygmomanometer as reference.

Published
2015
Full Text
View/download PDF

25. PP.33.27

Author

Rattazzi, M., Sponchiado, A., Galliazzo, S., Buso, R., Pagliara, V., Puato, M., Zambon, A., Villalta, S., and Pauletto, P.

Abstract

Risk of arterial cardiovascular events is increased in patients with history of venous thromboembolism (VTE), although underlying mechanisms are still unclear. We previously found an increase prevalence of metabolic syndrome (MetS) among patients affected by VTE. In the present study we investigated the association between individual components of MetS and the risk of VTE recurrence.

Published
2015
Full Text
View/download PDF

Catalog

Books, media, physical & digital resources
See catalog results